Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies
Open accessThe DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index, and 1 are not checked yet; none of the 9 sources its claims cite is checked for support yet.
Abstract
BACKGROUND: Positive association between obesity and survival after breast cancer was demonstrated in previous meta-analyses of published data, but only the results for the comparison of obese versus non-obese was summarised. METHODS: We systematically searched in MEDLINE and EMBASE for follow-up studies of breast cancer survivors with body mass index (BMI) before and after diagnosis, and total and cause-specific mortality until June 2013, as part of the World Cancer Research Fund Continuous Update Project. Random-effects meta-analyses were conducted to explore the magnitude and the shape of the associations. RESULTS: Eighty-two studies, including 213 075 breast cancer survivors with 41 477 deaths (23 182 from breast cancer) were identified. For BMI before diagnosis, compared with normal weight women, the summary relative risks (RRs) of total mortality were 1.41 [95% confidence interval (CI) 1.29-1.53] for obese (BMI >30.0), 1.07 (95 CI 1.02-1.12) for overweight (BMI 25.0-<30.0) and 1.10 (95% CI 0.92-1.31) for underweight (BMI <18.5) women. For obese women, the summary RRs were 1.75 (95% CI 1.26-2.41) for pre-menopausal and 1.34 (95% CI 1.18-1.53) for post-menopausal breast cancer. For each 5 kg/m(2) increment of BMI before, <12 months after, and ≥12 months after diagnosis, increased risks of 17%, 11%, and 8% for total mortality, and 18%, 14%, and 29% for breast cancer mortality were observed, respectively. CONCLUSIONS: Obesity is associated with poorer overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained. Being overweight is also related to a higher risk of mortality. Randomised clinical trials are needed to test interventions for weight loss and maintenance on survival in women with breast cancer.
Checked 2026-10-11 · 1 reference not checked yet
Overview
CoChat Summary
## TL;DR
This systematic review and meta-analysis of 82 follow-up studies found that higher BMI was associated with worse overall and breast cancer survival in women with breast cancer, whether BMI was measured before diagnosis, <12 months after, or ≥12 months after diagnosis. It also found some increased mortality risk in overweight and underweight women and evidence of a J-shaped BMI–total mortality relationship.
## Key findings
- Across 79 publications from 82 follow-up studies, the meta-analyses included 41,477 deaths (23,182 from breast cancer) among 213,075 breast cancer survivors.
- For total mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.41 (95% CI 1.29–1.53; 21 studies)
- <12 months after diagnosis: RR 1.23 (95% CI 1.12–1.33; 24 studies)
- ≥12 months after diagnosis: RR 1.21 (95% CI 1.06–1.38; 5 studies)
- For breast cancer mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.35 (95% CI 1.24–1.47; 22 studies)
- <12 months after diagnosis: RR 1.25 (95% CI 1.10–1.42; 12 studies)
- ≥12 months after diagnosis: RR 1.68 (95% CI 0.90–3.15; 2 studies; not statistically significant)
- Linear dose–response analyses showed increased risk per 5 kg/m² higher BMI:
- Total mortality: RR 1.17 before diagnosis, 1.11 <12 months after, 1.08 ≥12 months after
- Breast cancer mortality: RR 1.18 before diagnosis, 1.14 <12 months after
- The paper reports a J-shaped association for total mortality and notes that risks were also elevated in overweight and, in some analyses, underweight women.
## Methods
- Design: Systematic literature review and meta-analysis of follow-up studies of women with breast cancer.
- Data/sample: English-language articles from OVID MEDLINE and EMBASE through 30 June 2013, plus hand-searching; included studies had to report BMI and total or cause-specific mortality. Final meta-analyses used 79 publications from 82 follow-up studies.
- Main analysis: Random-effects categorical and dose–response meta-analyses, including non-linear dose–response models; heterogeneity assessed with Cochran Q and I², with subgroup/meta-regression, sensitivity analyses, and publication-bias checks using Egger’s test and funnel plots.
## Limitations
- The paper states that most studies did not adjust for co-morbidities and did not assess intentional weight loss; body weight and treatment information were often incomplete or unavailable.
- It notes that reverse causation may have affected studies assessing BMI in women with cancer and other illnesses, and that survival bias in survivor cohorts may underestimate associations.
- The text also says the review could not analyze race/ethnicity or treatment types because too few studies reported them; this is an evident limitation of the evidence base, not just the review.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
0 Valid · 0 Not valid · 9 Not checked · 67 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BMI was significantly associated with breast cancer mortality.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
states an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The current systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre and postmenopausal breast cancer, regardless of when BMI is ascertained.”
- Also stated in: § discussion · boosted
“The present systematic literature review and meta-analysis of follow-up studies clearly supports that, in breast cancer survivors, higher BMI is consistently associated with lower overall and breast cancer survival, regardless of when BMI is ascertained.”
- Also stated in: § discussion · plain
“In conclusion, the present systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > Abstract
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § discussion · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared with normal weight women, for BMI before diagnosis, the summary RRs were 1.35 (95% CI 1.24–1.47, 22 studies) for obese women, 1.11 (95% CI 1.06–1.17, 21 studies) for overweight women, and 1.02 (95% CI 0.85–1.21, 8 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
47 more claims
Create a free account to see all 76 claims and to verify the 9 references still open.
- The quote only partly states this claim. 4
- It may state two separate claims as one. 16
- Probably not a substantial claim. 10
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“statistical analysis Categorical and dose-response meta-analyses were conducted using random-effects models to account for between-study heterogeneity[18].”
MethodQuantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“To assess heterogeneity, we computed the Cochran Q test and I 2 statistic[35].”
MethodFood, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050 · cited 1×
“be obese and 958 million were overweight in 2008[3].”
BackgroundPublication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282 · cited 1×
“Small study or publication bias was examined by Egger’s test[36] and visual inspection of the funnel plots.”
MethodNutrition and physical activity guidelines for cancer survivors
Rock, C. L., Doyle, C., Demark‐Wahnefried, W., Meyerhardt, J., Courneya, K. S., Schwartz, A. L., Bandera, E. V., Hamilton, K. K., Grant, B., McCullough, M., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21142 · Cited by 1,995
Self-citationGeneralized Least Squares for Trend Estimation of Summarized Dose–response Data
Orsini, N., Bellocco, R., & Greenland, S. (2006) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0600600103 · Cited by 1,241 · cited 1×
“generalised least-squares for trend estimation[25].”
The use of fractional polynomials to model continuous risk variables in epidemiology
Royston, P., Ambler, G., & Sauerbrei, W. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.5.964 · Cited by 1,066 · cited 1×
“The non-linear dose-response relationship between BMI and mortality was examined using the best-fitting second order fractional polynomial regression model[23], defined as the one with the lowest deviance.”
MethodFasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 981
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Protani, M., Coory, M., & Martin, J. H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0990-0 · Cited by 962 · cited 3×
“A review published in 2010 reported statistically significant increased risks of 33% of both total and breast cancer mortality for obesity versus non-obesity around diagnosis[7].”
Background
Research works printed but not linked: 2
- Tobias A Assessing the influence of a single study in meta-analysis Stata Tech Bull 1999 47 15 17
- Donegan WL Jayich S Koehler MR The prognostic implications of obesity for the surgical cure of breast cancer Breast 1978 4 14 17
Cited by
Items 501–600 of 1,000
Puklin, L. S., Harrigan, M., Cartmel, B., Sanft, T. B., Gottlieb, L. T., Zhou, B., Ferrucci, L. M., Li, F., Spiegelman, D. L., Sharifi, M., et al. (2023) · Cancers · doi:10.3390/cancers15194719 · Cited by 19
“Additionally, every 5 kg/m 2 increase in BMI following diagnosis is associated with a 29% higher risk of breast cancer-specific mortality [2].”
BackgroundInfluentialCourneya, K. S., McNeely, M. L., Culos-Reed, S. N., Vallance, J. K., Bell, G. J., Mackey, J. R., Matthews, C. E., Morielli, A. R., Cook, D., MacLaughlin, S., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2534-4 · Cited by 19
“A recent systematic review [5] of 79 studies reported that for BMI assessed within 12 months of diagnosis, the relative risk for obese women was 1.”
Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast)
O’Donnell, E., Shapiro, Y. N., Comander, A. H., Isakoff, S. J., Moy, B., Spring, L. M., Wander, S. A., Kuter, I., Shin, J. A., Specht, M. C., et al. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06594-4 · Cited by 18
Sathiaraj, E., Afshan, K., Sruthi, R., Jadoni, A., Murugan, K., Patil, S., & Naik, R. (2022) · Nutrition and Cancer · doi:10.1080/01635581.2022.2159044 · Cited by 18
“This is a particularly relevant effect in the clinical context of breast cancer, as BMI before and after cancer diagnosis and weight gain after diagnosis has been associated with increased mortality (53, 54).”
BackgroundGnagnarella, P., Dragà, D., Raja, S., Baggi, F., Simoncini, M. C., Sabbatini, A., Mazzocco, K., Masiero, M. A., Bassi, F. D., Peradze, N., et al. (2023) · Journal of Cancer Survivorship · doi:10.1007/s11764-023-01415-z · Cited by 18
Carpenter, D. J., Peluso, C., Hilton, C. J., Velasquez, F., Annichine, A., Matsko, K., Rosenberg, J., Diaz, A. K., Hyde, P. N., Beriwal, S., et al. (2024) · Cancer Medicine · doi:10.1002/cam4.7001 · Cited by 18
Hauner, D., Günther, J., Schederecker, F., Donik, L., Meyer, D. M., Hermsdörfer, J., Friedl, T. W. P., Rack, B. K., Beckmann, M. W., Janni, W. J., et al. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.07.002 · Cited by 18
Falcone, M., Salhia, B., Halbert, C. H., Torres, E. T. R., Stewart, D. B., Stern, M. C., & Lerman, C. E. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-1359 · Cited by 18
Abdou, Y. G., Barlow, W. E., Gralow, J. R., Meric‐Bernstam, F., Albain, K. S., Hayes, D. F., Lin, N., Perez, E. A., Goldstein, L. J., Chia, S., et al. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae314 · Cited by 18
Physical Needs of Long-term Cancer Patients
Tralongo, P., Pescarenico, M. G., Surbone, A., Bordonaro, S., Berretta, M., & Mari, A. D. (2017) · Anticancer Research · doi:10.21873/anticanres.11880 · Cited by 18
Faroongsarng, D., Sunpaweravong, S., & Raksawong, A. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1356-5 · Cited by 18
Adult Overweight and Survival from Breast and Colorectal Cancer in Swedish Women
Arnold, M., Charvat, H., Freisling, H., Noh, H., Adami, H., Soerjomataram, I., & Weiderpass, E. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0075 · Cited by 18
Birts, C. N., Savva, C., Laversin, S. A., Lefas, A. Y., Krishnan, J. V., Schapira, A., Ashton‐Key, M., Crispin, M., Johnson, P., Blaydes, J. P., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-11696-6 · Cited by 18
Oh, M., Batty, S. R., Banerjee, N., & Kim, T.-H. (2023) · Molecular Biology of the Cell · doi:10.1091/mbc.e22-12-0560 · Cited by 18
“Recent studies have shown increased breast cancer-specific death in obese breast cancer patients (Protani et al. , 2010; Chan et al. , 2014; Blair et al. , 2019).”
Crispo, A., Grimaldi, M., D’Aiuto, M., Rinaldo, M., Capasso, I., Amore, A., D’Aiuto, G., Giudice, A., Ciliberto, G., & Montella, M. (2014) · The Breast · doi:10.1016/j.breast.2014.11.005 · Cited by 18
Obesity: an heavyweight player in breast cancer’s chemoresistance
Vaysse, C., Muller, C., & Fallone, F. (2019) · Oncotarget · doi:10.18632/oncotarget.26905 · Cited by 18
Gaculenko, A., Gregoric, G., Popp, V., Seyler, L., Ringer, M., Kachler, K., Wu, Z., Kisel, W., Hofbauer, C., Hofbauer, L. C., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4422 · Cited by 18
Disparities in Obesity, Physical Activity Rates, and Breast Cancer Survival
Ford, M. E., Magwood, G., Brown, E., Cannady, K., Gregoski, M. J., Knight, K. D., Peterson, L. L., Kramer, R. M., Knowell, A. E., & Turner, D. P. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.08.002 · Cited by 18
Dana, N., Ferns, G. A., Nedaeinia, R., & Javanmard, S. H. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02988-4 · Cited by 17
“The other meta-analysis of 82 studies indicated that obesity decreased overall and breast cancer survival in pre-and post-menopausal breast cancer and overweight is related to a higher risk of mortality [35].”
BackgroundResultAssociation of body composition and surgical outcomes in patients with early-stage breast cancer
Aleixo, G. F. P., Valente, S. A., Wei, W., & Moore, H. C. F. (2023) · Breast Cancer Research and Treatment · doi:10.1007/s10549-023-07060-5 · Cited by 17
Xie, H., Wei, L., Zhang, H., Ruan, G., Liu, X., Lin, S., Shi, J., Liu, C., Zheng, X. M., Chen, Y., et al. (2023) · Inflammation Research · doi:10.1007/s00011-023-01832-x · Cited by 17
Exploring the multifaceted role of obesity in breast cancer progression
Kakkat, S., Suman, P., Herrera, E. A. T., Singh, S., Chakroborty, D., & Sarkar, C. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1408844 · Cited by 17
Zhao, G., Zhang, X., Meng, L., Dong, K., Shang, S., Jiang, T., Liu, Z., & Gao, H. (2024) · Oncogene · doi:10.1038/s41388-024-03161-7 · Cited by 17
Llanos, A. A. M., Lin, Y., Chen, W., Yao, S., Norin, J., Chekmareva, M. A., Omene, C. O., Cong, L., Omilian, A. R., Khoury, T., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-1256-3 · Cited by 17
Self-citationda Silva, B. R., Rufato, S., Mialich, M. S., Cruz, L. P., Gozzo, T. D. O., & Jordão, A. A. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.06.001 · Cited by 17
Unraveling the Role of Adiponectin Receptors in Obesity-Related Breast Cancer
Naimo, G. D., Paolì, A., Giordano, F., Forestiero, M., Panno, M. L., Andò, S., & Mauro, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108907 · Cited by 17
“A meta-analysis of 82 follow-up studies showed a 35% higher risk of breast cancer m rtality in obese wom n than in their normal-weight counterparts, ascribing obesity to a relevant role s a risk factor for breast tumorigene is [75].”
BackgroundAssociated factors with mammographic changes in women undergoing breast cancer screening
de Sant'Ana, R. S., Mattos, J. S. D. C., da Silva, A. S., de Mello, L. M., & Nunes, A. A. (2016) · Einstein (São Paulo) · doi:10.1590/s1679-45082016ao3708 · Cited by 17
“(20) Of note is that some studies report categorical data that excessive body fat represents a risk factor to increase incidence of breast cancer, particularly among women in postmenopausal period.(21,22) Based on this fact, it is necessary to identify how obesity can affect and change organism of these women.”
BackgroundCox, M. G., Basen‐Engquist, K., Carmack, C. L., Blalock, J. A., Li, Y., Murray, J. L., Pisters, L. L., Rodríguez-Bigas, M. A., Song, J., Cox-Martin, E., et al. (2017) · JMIR Cancer · doi:10.2196/cancer.7166 · Cited by 17
“Two meta-analyses in breast and prostate cancer survivors showed that postdiagnosis increases in body mass index (BMI) are significantly associated with greater recurrence as well as poorer disease-free and overall survival [10,11].”
Lessons from Hippocrates: Time to Change the Cancer Paradigm
Galmarini, C. M. (2020) · International Journal of Chronic Diseases · doi:10.1155/2020/4715426 · Cited by 17
Fukumoto, K., Mori, S., Shintani, Y., Okami, J., Ito, H., Ohtsuka, T., Toyooka, S., Mori, T., WATANABE, S.-I. J., Asamura, H., et al. (2020) · Lung Cancer · doi:10.1016/j.lungcan.2020.09.011 · Cited by 17
Effect of weight loss on bone health in overweight/obese postmenopausal breast cancer survivors
Toriola, A. T., Liu, J., Ganz, P. A., Colditz, G. A., Yang, L., Izadi, S. R., Naughton, M. J., Schwartz, A. L., & Wolin, K. Y. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3496-y · Cited by 17
“Although elevated body mass index (BMI) is associated with worse breast cancer survival [1], a high BMI correlates strongly with BMD and may be protective for bone health [21, 33].”
Backgroundvan Maldegem, S. J. M. V. C. –., Mols, F., Horevoorts, N. J. E., de Kruif, A. J. T. C. M., Buffart, L. M., Schoormans, D., Trompetter, H. R., Beijer, S., Ezendam, N. P. M., de Boer, M. R., et al. (2021) · BMC Women s Health · doi:10.1186/s12905-021-01406-1 · Cited by 16
“Excess body weight and body fat distribution will be determined by self-reported height and weight with which we calculate BMI [15] and self-measured hip- and waist circumference [40].”
MethodAl-Shibli, S. M., Amjad, N. M., Al-Kubaisi, M. K. D., & Mizan, S. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.165 · Cited by 16
Association of body composition with clinical outcome in Chinese women diagnosed with breast cancer
Liu, X., Zhang, E., Wang, S., Shen, Y., Xi, K., & Fang, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.957527 · Cited by 16
Reported Mental Health, Diet, and Physical Activity in Young Adult Cancer Survivors
Buro, A. W., Stern, M., & Carson, T. L. (2023) · Nutrients · doi:10.3390/nu15041005 · Cited by 16
Zhao, F., Liu, J., Fang, X., Chen, L., Liang, J.-G., Liu, Y., Li, R., & Chen, H. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-023-08300-6 · Cited by 16
“For each 5 kg/m 2 increment in BMI before, 12 months after, and ≥ 12 months after diagnosis, the total mortality and breast cancer-related mortality risks increased by 17%, 11%, and 8%, and 18%, 14%, and 29%, respectively [9].”
Nutrition care of cancer patients-A survey among physicians and nurses
Erickson, N. T., Paradies, K., Buchholz, D., & Hübner, J. (2018) · European Journal of Cancer Care · doi:10.1111/ecc.12855 · Cited by 16
Cardio-oncology rehabilitation: are we ready?
Bisceglia, I., Venturini, E., Canale, M. L., Ambrosetti, M., Riccio, C., Giallauria, F., Gallucci, G., Abrignani, M. G., Russo, G., Lestuzzi, C., et al. (2024) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suae030 · Cited by 15
Ligibel, J. A., Ballman, K. V., McCall, L. M., Goodwin, P. J., Alfano, C. M., Bernstein, V., Crane, T. E., Delahanty, L. M., Frank, E. S., Hahn, O. M., et al. (2025) · JAMA Oncology · doi:10.1001/jamaoncol.2025.2738 · Cited by 15
Ruan, G., Zhu, L., Xie, H., Zhang, H., Song, M., Deng, L., & Shi, H. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02713-4 · Cited by 15
Lee, J. W., Kim, S. Y., Lee, H. J., Han, S. W., Lee, J. E., & Lee, S. M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091358 · Cited by 15
Bergamino, M. A., Fernández-Ortega, A., Stradella, A., Morilla, I., Falo, C., Vázquez, S., Castany, R., Villanueva, R., Recalde, S., Pérez, V. N., et al. (2019) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-019-0367-x · Cited by 15
Cha, J.-Y., Park, J., Hong, Y.-K., Jeun, S., & Ahn, S. (2021) · Integrative Cancer Therapies · doi:10.1177/1534735421991233 · Cited by 15
Brandão, M., Guisseve, A., Damasceno, A. A. M., Bata, G., Silva‐Matos, C., Alberto, M., Ferro, J., García, C., Zaqueu, C., Lorenzoni, C. F., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1730 · Cited by 15
Monk, J. M., Liddle, D. M., Hutchinson, A. L., Burns, J. L., Wellings, H. R., Cartwright, N. M., Muller, W. J., Power, K. A., Robinson, L. E., & David, W. L. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108763 · Cited by 15
Groef, A. D., Demeyer, H., de Kinkelder, C., Althuis, S. D.-V., Asnong, A., Dams, L., der Gucht, E. V., Vrieze, T. D., Haenen, V., Evenepoel, M., et al. (2021) · Clinical Breast Cancer · doi:10.1016/j.clbc.2021.12.006 · Cited by 15
Impacts of nutritive and bioactive compounds on cancer development and therapy
Sultana, S., Bouyahya, A., Ребезов, М. Б., Shariati, M. A., Balahbib, A., Khouchlaa, A., Yaagoubi, O. M. E., Khaliq, A., Omari, N. E., Bakrim, S., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2062699 · Cited by 15
“Obesity is not only associated with increased BC risk, but also with recurrence of BC (Biganzoli et al. 2017) and mortality (Chan et al. 2014).”
BackgroundLongitudinal Changes in Circulating Metabolites and Lipoproteins After Breast Cancer Treatment
Giskeødegård, G. F., Madssen, T. S., Sangermani, M., Lundgren, S., Wethal, T., Andreassen, T., Reidunsdatter, R. J., & Bathen, T. F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.919522 · Cited by 15
Luís, C., Dias, J., Machado, J. F., Fernandes, R., Pereira, D., Baylina, P., Fernandes, R., & Soares, R. A. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06836-5 · Cited by 15
Chen, H., Zhang, F., Luo, D., Guo, J., Lin, Y., Chen, S., Yin, S., Chen, X., Peng, J., & Lian, L. (2023) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-22-657 · Cited by 15
Associations of Post-Diagnosis Lifestyle with Prognosis in Women with Invasive Breast Cancer
Troeschel, A. N., Hartman, T. J., McCullough, L. E., Ergas, I. J., Collin, L. J., Kwan, M. L., Ambrosone, C. B., Flanders, W. D., Bradshaw, P. T., Feliciano, E. M. C., et al. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-1274 · Cited by 15
Blyth, R. R. R., Birts, C. N., & Beers, S. A. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01700-w · Cited by 15
“However, there is increasing evidence that a high BMI is associated with poorer prognosis in BC patients of all ages [6, 7].”
BackgroundBody adipose tissue depots and treatment outcomes for women with breast cancer: A systematic review
Poltronieri, T. S., Pérsico, R. S., & Viana, L. V. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.03.010 · Cited by 15
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin
Barba, M., Pizzuti, L., Sperduti, I., Natoli, C., Gamucci, T., Sergi, D., Lauro, L. D., Moscetti, L. I., Izzo, F., Rinaldi, M., et al. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25213 · Cited by 15
“…observational studies and intervention trials tend to show higher mortality rates, both all cause and disease specific, in breast cancer patients with higher BMI compared to their leaner counterpart, independently on hormone receptors and menopausal status (Chan et al., 2014; Kwan et al., 2014).”
BackgroundVargas-Meza, A., Chávez‐Tostado, M., Cortés‐Flores, A. O., Urias-Valdez, D. P., Delgado-Gómez, M., Morgan‐Villela, G., Valle, C. Z.-F. D., Jiménez-Tornero, J., Valle, R. Z.-F. D., Fuentes‐Orozco, C., et al. (2016) · European Journal of Cancer Care · doi:10.1111/ecc.12550 · Cited by 15
Elwood, M., Tin, S. T., Kuper-Hommel, M. J. J., Lawrenson, R. A., & Campbell, I. (2018) · BMC Cancer · doi:10.1186/s12885-017-3971-4 · Cited by 15
“Effects through these mechanisms would be expected to be greater in post-menopausal women; however, in the meta-analysis noted no difference in effects by menopausal status was seen [1].”
InfluentialJones, L. M., Stoner, L. R., Brown, C., Baldi, J. C., & McLaren, B. R. (2019) · Breast Cancer · doi:10.1007/s12282-019-00975-2 · Cited by 15
Hauner, D., Rack, B. K., Friedl, T. W. P., Hepp, P. G., Janni, W. J., & Hauner, H. (2020) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2020-000119 · Cited by 15
Ligorio, F., Zambelli, L., Bottiglieri, A., Castagnoli, L., Zattarin, E., Lobefaro, R., Ottini, A., Vingiani, A., Pupa, S. M., Bianchi, G., et al. (2021) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359211006960 · Cited by 15
Body mass index and type 2 diabetes and breast cancer survival: a Mendelian randomization study.
Liu, Y.-S., Wu, P., Chou, W., Vikram, R., Chen, W.-T., Yang, S.-L., Bolla, M. K., Wang, Q., Dennis, J., Chan, T. L., et al. (2021) · PubMed Central · doi:10.17863/cam.73616 · Cited by 15
Barry, A. S., Rock, K., Sole, C. V., Rahman, M. A., Pintilie, M., Lee, G., Fyles, A., & Koch, C. A. (2016) · Practical Radiation Oncology · doi:10.1016/j.prro.2016.11.010 · Cited by 15
Vijayasiri, G., Molina, Y., Chukwudozie, I. B., Tejeda, S., Pauls, H. A., Rauscher, G. H., Campbell, R. T., & Warnecke, R. B. (2018) · PubMed · Cited by 15
Body Mass Index and Outcomes in Breast Cancer Treated With Breast Conservation
Patel, V., James, M. L., Frampton, C. M., Robinson, B. A., Davey, V., & Timmings, L. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.09.049 · Cited by 15
Addressing Obesity in Clinical Gynecology Practice
Kahan, S. I., & Winston, G. J. (2018) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000334 · Cited by 14
CE: Obesity-Related Cancer in Women: A Clinical Review
Katz, A. (2019) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000577332.56265.51 · Cited by 14
Johansson, K. I., & Hayes, S. C. (2020) · Lymphology · doi:10.2458/lymph.4655 · Cited by 14
Akinyemiju, T., Jones, K. A., Gupta, A., Oyekunle, T. O., Saraiya, V., Deveaux, A. E., Salako, O., Hall, A. H. S., Alatise, O. I., Ogun, G. O., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08775-8 · Cited by 14
Obesity and Breast Cancer Metastasis across Genomic Subtypes
Olsson, L. T., Walens, A., Hamilton, A. M., Benefield, H. C., Fleming, J. M., Carey, L., Hursting, S. D., Williams, K. P., & Troester, M. A. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0013 · Cited by 14
Bergman, R. E., Berko, Y. A., Sanchez, V. M., Sanders, M. E., Ericsson, P. I. G., Arteaga, C. L., & Rexer, B. N. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06794-y · Cited by 14
Christensen, R. A. G., Haykowsky, M. J., Nadler, M. B., Prado, C. M. M., Small, S. D., Rickard, J. N., Pituskin, E., Paterson, D. I., Mackey, J. R., Thompson, R. B., et al. (2022) · British Journal Of Nutrition · doi:10.1017/s0007114522003816 · Cited by 14
“The direct toxic effects of breast cancer treatment on the heart (cardiotoxicity) are well characterised as a contributor to elevated CVD risk (2) .”
The Role of BMI in Allostatic Load and Risk of Cancer Death
Andrzejak, S. E., Lewis‐Thames, M. W., Langston, M. E., Han, Y., Khan, S., Nettles, D. A., Fuzzell, L. N., Tingen, M. S., & Moore, J. X. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.03.002 · Cited by 14
Obesitas dan Kanker Payudara : Literature Review
Winasis, A., & Djuwita, R. (2023) · Media Publikasi Promosi Kesehatan Indonesia (MPPKI) · doi:10.56338/mppki.v6i8.3501 · Cited by 14
Pedersini, R., Laganà, M., Bosio, S., Zanini, B., Cosentini, D., di Mauro, P., Alberti, A., Schivardi, G., Laini, L., Ippolito, G., et al. (2023) · Breast Cancer Research and Treatment · doi:10.1007/s10549-023-07095-8 · Cited by 14
Scheibler, J., Silva, F. M., Moreira, T. R., & Adami, F. S. (2016) · Revista Brasileira em Promoção da saúde · doi:10.5020/18061230.2016.p544 · Cited by 14
Derksen, J. W. G., Beijer, S., Koopman, M., Verkooijen, H. M., van de Poll-Franse, L. V., & May, A. M. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.06.017 · Cited by 14
Scheich, S., Enssle, J. C., Mücke, V. T., Acker, F., Aspacher, L., Wolf, S., Wilke, A. C., Weber, S., Brunnberg, U., Serve, H. L., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225035 · Cited by 14
“Obesity is associated with an inferior outcome in cancer patients[18, 22, 23].”
BackgroundDigital analysis of distant and cancer-associated mammary adipocytes
Isnaldi, E., Richard, F., Schepper, M. D., Vincent, D., Leduc, S., Maetens, M., Geukens, T., Floris, G., Rouas, G., Cardoso, F., et al. (2020) · The Breast · doi:10.1016/j.breast.2020.10.004 · Cited by 14
“Additionally, obesity has been shown to negatively impact the prognosis of BC patients [14,15].”
BackgroundIbrahim, A. S., El‐Shinawi, M., Sabet, S., Ibrahim, S., & Mohamed, M. M. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01678-y · Cited by 14
Oudanonh, T., Nabi, H., Ennour‐Idrissi, K., Lemieux, J., & Diorio, C. (2019) · International Journal of Cancer · doi:10.1002/ijc.32621 · Cited by 14
“Two meta-analyses reported that obese women diagnosed with BC had a higher risk of death or recurrence than non-obese women.(4,5) In addition, evidence for this association seems to be more consistent for women with ER+ BC.”
BackgroundKast, K., John, E. M., Hopper, J. L., Andrieu, N., Noguès, C., Mouret‐Fourme, E., Lasset, C., Fricker, J., Berthet, P., Mari, V., et al. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01673-w · Cited by 13
“If the same is true for variant carriers, the inverse association with high BMI might be overestimated [55].”
BackgroundThe impact of obesity on treatment choices and outcomes in operable breast cancer
Burkheimer, E., Starks, L., Khan, M., Oostendorp, L. D., Melnik, M. K., Chung, M. H., & Wright, G. P. (2018) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2018.10.048 · Cited by 13
Yang, P., He, Y., Yu, X., Liu, B., Wang, X., Li, X., & Wang, P. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001988 · Cited by 13
Zhu, S., Tong, Y., Chen, W., Chen, X., & Shen, K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.862224 · Cited by 13
IGF-1 Stimulates Glycolytic ATP Production in MCF-7L Cells
Rajoria, B., Zhang, X., & Yee, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210209 · Cited by 13
“In postmenopausal ER+ and PR+ breast cancer patients, obesity has been associated with breast cancer progression [34,35].”
BackgroundChen, H., Qian, X., Tao, Y., Wang, D., Wang, Y., Yu, Y., & Yao, H. (2023) · The Breast · doi:10.1016/j.breast.2023.07.002 · Cited by 13
Holm, J. B., Baggesen, E., Cronin-Fenton, D. P., Frystyk, J., Bruun, J. M., Christiansen, P., & Borgquist, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-64428-3 · Cited by 13
Le, Y., Gao, Z., Gomez, S. L., Pope, Z., Dong, R., Allen, L., Chang, M., & Wang, J. H.-Y. (2018) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-018-0721-x · Cited by 13
“Notably, obesity is associated with poorer breast cancer survival [61, 62].”
Obesity and mortality after locoregional breast cancer diagnosis
Moore, A. H., Trentham‐Dietz, A., Burns, M. E., Gangnon, R. E., Greenberg, C. C., Vanness, D. J., Hampton, J. M., Wu, X., Anderson, R. T., Lipscomb, J., et al. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4932-6 · Cited by 13
Impact of physical activity and energy restriction on immune regulation of cancer
Xu, Y., & Rogers, C. J. (2020) · Translational Cancer Research · doi:10.21037/tcr.2020.03.38 · Cited by 13
“Although the association between obesity and cancer survival is debated (9), obesity is associated with lower survival in patients with ovarian (10), endometrial (11), and breast cancer (12,13).”
BackgroundKałędkiewicz, E., Milewska, M., Pańczyk, M., & Szostak-Węgierek, D. E. (2020) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s274660 · Cited by 14
Randomized trial of weight loss on circulating ghrelin levels among breast cancer survivors
Puklin, L. S., Cartmel, B., Harrigan, M., Lu, L., Li, F., Sanft, T. B., & Irwin, M. L. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00260-6 · Cited by 13
Fat-enlarged axillary lymph nodes are associated with node-positive breast cancer in obese patients
diFlorio‐Alexander, R. M., Song, Q., Dwan, D., Austin-Strohbehn, J. A., Muller, K. E., Kinlaw, W. B., MacKenzie, T. A., Karagas, M. R., & Hassanpour, S. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06262-z · Cited by 13
Lee, E., Kawaguchi, E. S., Zhang, J., Kim, S. E., Deapen, D., Liu, L., Sheidaee, N., Hwang, A. E., Kang, I. M., Sandhu, K. K., et al. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.09.017 · Cited by 13
Chen, S.-T., Lai, H., Wu, W.-P., Chen, S., Liao, C., Wu, H., Chen, D., & Mok, C. W. (2022) · World Journal of Surgical Oncology · doi:10.1186/s12957-022-02520-6 · Cited by 13
Li, F., Song, X., Zhou, X., Chen, L., & Zheng, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17052 · Cited by 13
Flote, V. G., Frydenberg, H., Ursin, G., Iversen, A., Fagerland, M. W., Ellison, P. T., Wist, E. A., Egeland, T., Wilsgaard, T., McTiernan, A., et al. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0267 · Cited by 13
Self-citationRisk Reduction from Weight Management and Physical Activity Interventions
Irwin, M. L., Fabian, C. J., & McTiernan, A. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16366-6_13 · Cited by 13
Self-citationBezerra, Á. D. D. L., Pereira, J. P. D. C., Soares, I. F. D. M., Ferreira, G. M. C., Miranda, A. L., de Medeiros, G. O. C., Verde, S. M. M. L., & Fayh, A. P. T. (2024) · Nutrients · doi:10.3390/nu16183175 · Cited by 12
Breast Cancer Risk and Management in the Endocrine Clinic: A Comprehensive Review
Hawazie, A., & Druce, M. R. (2025) · Clinical Endocrinology · doi:10.1111/cen.15209 · Cited by 12
Risk Factors and Prevention of Cancer and CVDs: A Chicken and Egg Situation
Abrignani, M. G., Lucà, F., Abrignani, V., Nucara, M., Grosseto, D., Lestuzzi, C., Mistrangelo, M., Passaretti, B., Rao, C. M., & Parrini, I. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14093083 · Cited by 12
Metadata
- Authors
- Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T.
- Affiliations
- Imperial College London (GB)
- Norwegian University of Science and Technology (NO)
- Rutgers, The State University of New Jersey (US)
- University of Leeds (GB)
- Fred Hutch Cancer Center (US)
- Oslo University Hospital (NO)
- Newcastle University (GB)
- Corresponding author
- Chan, D.S.M.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 25
- Issue
- 10
- Pages
- 1901-1914
- ISSN
- 0923-7534 (ISSN-L)
- PMC
- PMC4176449
- OpenAlex
- W2149466392
- Cited by
- 1,165
- References
- 123
- Citations by year
- 2026: 57 · 2025: 69 · 2024: 97 · 2023: 117 · 2022: 132 · 2021: 117 · 2020: 121 · 2019: 103 · 2018: 97 · 2017: 98 · 2016: 85 · 2015: 58 · 2014: 12
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 1878 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by-nc-nd)
- HighWire Press Open Archive (submittedVersion)
- Funders
- World Cancer Research Fund International (2007/SP01)
- World Cancer Research Fund International/American Institute for Cancer Research
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- body mass index, breast cancer, obesity, overweight, underweight, survival, mortality, cause-specific mortality, menopausal status, weight loss interventions, cancer survivorship
- MeSH terms
- Breast Neoplasms, Female, Follow-Up Studies, Humans, Obesity, Prognosis, Risk Factors, Body Mass Index, Randomized Controlled Trials as Topic, MEDLINE, Survivors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.